U07.1 Billable / specific COVID-19

ICD-10-CM U07.1 identifies “COVID-19” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 22: Codes for special purposes

Code-level instructions

Excludes 22
  • coronavirus as the cause of diseases classified elsewhere (B97.2-)
  • pneumonia due to SARS-associated coronavirus (J12.81)
Use additional code7
  • code to identify pneumonia or other manifestations, such as:
  • pneumonia due to COVID-19 (J12.82)
  • code, if applicable, for associated conditions such as:
  • COVID-19 associated coagulopathy (D68.8)
  • disseminated intravascular coagulation (D65)
  • hypercoagulable states (D68.69)
  • thrombophilia (D68.69)
Official index references

Official index references (9)

Coronavirus(infection) (3)
COVID-19 (1)
Disease, diseased (1)
Infection, infected, infective(opportunistic) (3)
Syndrome (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2020-04-01

Previous assignment: B97.29

References from other codes (4)
History

Code history

Latest recorded change · FY2024

ChangedUnchanged
FY2024

Effective from

  • Code-level rules changed

COVID-19

Billable diagnosis code

CDC/NCHS · FY2024

All editions (14)

All editionsEffective fromCode history
FY2020 · April2020-04-01Added
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01Code-level rules changed
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01Code-level rules changed
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.